NO154130C - ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2-AMINOALKYL-5-PYRIDINOLS. - Google Patents

ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2-AMINOALKYL-5-PYRIDINOLS.

Info

Publication number
NO154130C
NO154130C NO801267A NO801267A NO154130C NO 154130 C NO154130 C NO 154130C NO 801267 A NO801267 A NO 801267A NO 801267 A NO801267 A NO 801267A NO 154130 C NO154130 C NO 154130C
Authority
NO
Norway
Prior art keywords
formula
xii
preparation
pyridinols
aminoalkyl
Prior art date
Application number
NO801267A
Other languages
Norwegian (no)
Other versions
NO154130B (en
NO801267L (en
Inventor
Renat Herbert Mizzoni
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO801267L publication Critical patent/NO801267L/en
Publication of NO154130B publication Critical patent/NO154130B/en
Publication of NO154130C publication Critical patent/NO154130C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Building Environments (AREA)
  • Paper (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

There is described a process for preparing an enamine of formula (IX): <IMAGE> where R<2> is a carboxylic acid protecting group and R<3> is the residue of a carboxylic acid derived acyl group and where R<5> and R<6> are the same or different C1-4 alkyl or C1-10 aralkyl groups; or taken together with the adjacent nitrogen atom form a heterocyclic ring containing from 4 to 8 carbon atoms and optionally a further heteroatom selected from oxygen and nitrogen; by reacting a compound of formula (XII): <IMAGE> with an amine of formula HNR<5>R<6>, the reactant of formula (XII) being prepared by reaction of an appropriate enol derivative with a phosphorus reagent. The enamines of formula (IX) are useful in the preparation of 3- hydroxycephalosporins. The compounds of formula (XII) are novel.
NO801267A 1979-05-03 1980-04-30 ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2-AMINOALKYL-5-PYRIDINOLS. NO154130C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3566879A 1979-05-03 1979-05-03

Publications (3)

Publication Number Publication Date
NO801267L NO801267L (en) 1980-11-04
NO154130B NO154130B (en) 1986-04-14
NO154130C true NO154130C (en) 1986-07-23

Family

ID=21884070

Family Applications (1)

Application Number Title Priority Date Filing Date
NO801267A NO154130C (en) 1979-05-03 1980-04-30 ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2-AMINOALKYL-5-PYRIDINOLS.

Country Status (19)

Country Link
EP (1) EP0019739B1 (en)
JP (1) JPS55149260A (en)
AT (1) ATE8501T1 (en)
DD (1) DD150461A5 (en)
DE (1) DE3068577D1 (en)
DK (1) DK157540C (en)
ES (1) ES491055A0 (en)
FI (1) FI70212C (en)
GB (1) GB2050380B (en)
GR (1) GR68206B (en)
HU (1) HU181115B (en)
IE (1) IE49712B1 (en)
IL (1) IL59978A (en)
MA (1) MA18964A1 (en)
NO (1) NO154130C (en)
OA (1) OA06528A (en)
PL (1) PL223984A1 (en)
PT (1) PT71176A (en)
ZW (1) ZW9680A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746670A (en) * 1986-04-11 1988-05-24 Ciba-Geigy Corporation Use of 2-aminoalkyl-5-pyridinols as nootropic agents and antidepressants
JP4732662B2 (en) * 2000-04-06 2011-07-27 セイコーインスツル株式会社 Battery holding structure for electronic watch

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3952101A (en) * 1975-04-14 1976-04-20 Smithkline Corporation α-Amino methyl-5-hydroxy-2-pyridinemethanols

Also Published As

Publication number Publication date
DE3068577D1 (en) 1984-08-23
FI70212C (en) 1986-09-15
ATE8501T1 (en) 1984-08-15
IE49712B1 (en) 1985-11-27
GB2050380A (en) 1981-01-07
DK157540B (en) 1990-01-22
IL59978A0 (en) 1980-07-31
DK157540C (en) 1990-06-11
PL223984A1 (en) 1981-02-13
DD150461A5 (en) 1981-09-02
HU181115B (en) 1983-06-28
DK193180A (en) 1980-11-04
ES8104229A1 (en) 1981-04-01
ES491055A0 (en) 1981-04-01
NO154130B (en) 1986-04-14
JPS6365662B2 (en) 1988-12-16
PT71176A (en) 1980-05-01
NO801267L (en) 1980-11-04
ZW9680A1 (en) 1980-11-26
EP0019739A1 (en) 1980-12-10
IE800899L (en) 1980-11-03
FI801411A (en) 1980-11-04
OA06528A (en) 1981-07-31
GR68206B (en) 1981-11-10
EP0019739B1 (en) 1984-07-18
MA18964A1 (en) 1980-12-31
JPS55149260A (en) 1980-11-20
FI70212B (en) 1986-02-28
IL59978A (en) 1984-03-30
GB2050380B (en) 1983-07-20

Similar Documents

Publication Publication Date Title
DE3363244D1 (en) Compounds, process for their preparation and their use as pharmaceutical preparations
DK182081A (en) PROCEDURE FOR THE PREPARATION OF HYDROXAMIC ACIDS
ES8104286A1 (en) 1,8-Naphthyridine derivatives, their preparation, pharmaceutical compositions containing them.
PT87277A (en) PROCESS FOR THE PREPARATION OF NEW BICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME
NO154130C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2-AMINOALKYL-5-PYRIDINOLS.
ES8104309A1 (en) Process for preparing enamine derivatives, compounds so produced and process for preparing a 3-hydroxy-cephalosporin.
ES8609195A1 (en) Process for preparing anti-inflammatory cycloalkylidenemethylphenylacetic acid derivatives.
ES8703475A1 (en) Process for preparing milbemycin derivatives and certain novel compounds employed therein.
ES485835A1 (en) Thienylbenzoic-acid derivatives, process for their production, and pharmaceutical preparations containing these compounds.
BG41128A3 (en) Method for prepparing intermediary compounds for preparation of benzothiazine- carboxamides
GB871235A (en) Novel substituted pyrrolidones and salts thereof and a process for the manufacture of same
DE3269453D1 (en) Process for the preparation of carboxylic acid anhydrides
ES451113A1 (en) Improvement of organic compound
DK145948C (en) PROCEDURE FOR PREPARING SULPHONIMIDOYLXANTHON-2-CARBOXYLIC ACID DERIVATIVES
ES473484A1 (en) A procedure for the preparation of new eteres of the clavulan acid (Machine-translation by Google Translate, not legally binding)
ES478502A1 (en) N-(pyridothienopyrazol) amides, process for their preparation and pharmaceutical compositions containing them.